PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-07-18 (2)

Date Title Company
18-Jul-2023 Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201 Businesswire